Revised SPCs: Intelence (etravirine) tablets – all strengths

The SPCs have been revised to reflect licence extension to cover the use of etravirine, in combination with a boosted protease inhibitor and other antiretroviral medicinal products for HIV 1 infection, for patients from 2 years of age.

Source:

electronic Medicines compendium